Justin Boyd — Senator Boyd was recognized and raised a previously unanswered concern about whether affiliate pharmacies are paid more than independent pharmacies. He said he had been waiting months for an answer and wanted the issue reviewed further, and his concern was then acknowledged by another speaker.
Dave Wallace — Mr. Wallace is thanked after his presentation and then called on in the same exchange, with the speaker expressing appreciation for his contribution.
Grant Wallace — Grant Wallace, the Director of EBD, was introduced to present the items for the record, and in the ensuing discussion he explained that some questions were still being studied and that the team did not yet have all the answers but was actively looking into them.
Grant Wallace — Introduced the February 2026 medical drug recommendations and explained that several items are biosimilars coming to market.